Get notified when RANI files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts

Critical incident detected

Fraud / investigation

Time-sensitive event — see the red-flag panel below for the source-quoted detail.

Red Flags Detected

  • Material Weakness (new) — Company identified material weakness in controls over complex transaction accounting that could result in material misstatement.
  • Delisting (worsened) — Active Nasdaq bid price deficiency notice with 180-day cure period ending November 9, 2026; prior period only warned of potential future noncompliance.
  • Going Concern (removed) — Baseline disclosed substantial doubt about going concern with cash runway to early August 2025; current filing omits this language entirely.
NASDAQ: RANI Rani Therapeutics Holdings, Inc. 10-Q

RANI: revenue $1.7M, net income -$7.0M. Rani exits going-concern crisis; controls deemed ineffective

Filed May 15, 2026 · Period ending March 31, 2026 · Compared to 10-Q May 13, 2025 · ~2 min read

Key Changes

  • high

    Management concluded disclosure controls are ineffective due to material weakness in accounting for complex transactions. While no prior misstatements occurred, the weakness could allow future material errors to go undetected.

    Controls & Procedures verify on EDGAR →
  • high

    Nasdaq issued bid price deficiency notice May 11, 2026 after stock traded below $1.00 for 30 days. Company has until November 9 to regain compliance or face delisting; reverse stock split under consideration.

    Risk Factors: Nasdaq Compliance verify on EDGAR →
  • high

    Going-concern doubt removed after cash improved from $15.9M to $43.4M year-over-year. Chugai collaboration generated $1.7M revenue in Q1 2026 vs. $0.2M prior year, and company eliminated $0.9M quarterly interest expense.

    MD&A: Liquidity verify on EDGAR →

2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (MU 10-K) is open in full — no account needed.

Partner

Trade RANI commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?
View original filing on SEC.gov View full financials on EDGAR ↗

Figures/quotes linked to EDGAR · Narrative written by AI · Jun 1, 2026 · How we verify